Latest News
Intellia stock plunges after FDA places clinical hold on its Phase 3 trials for lead candidate nex-z, overshadowing Q3 earnings.
Via Chartmill · November 6, 2025
Arlo's Q3 2025 results show a revenue miss but a solid earnings beat. The company highlighted strong growth in its subscription services and record profitability.
Via Chartmill · November 6, 2025
Digital media company Ziff Davis (NASDAQ:ZD) fell short of the markets revenue expectations in Q3 CY2025 as sales rose 2.9% year on year to $363.7 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.47 billion at the midpoint. Its non-GAAP profit of $1.76 per share was 1.4% below analysts’ consensus estimates.
Via StockStory · November 6, 2025
Lean hog futures posted 95 cent to $1.62 losses on Thursday. USDA’s national base hog price from Thursday afternoon was reported at $84.31, down $1.69 from the day prior. The CME Lean Hog Index was down another 4 cents on November 4 at $90.86. USDA’...
Via Barchart.com · November 6, 2025
The wheat market sold the fact of China purchases on Thursday, with losses across most contracts. CBT soft red wheat futures were 18 to 20 cents in the red across most contracts. KC HRW futures fell 16 to 18 cents in the front months on Thursday. MP...
Via Barchart.com · November 6, 2025
Live cattle futures were down 85 cents to $1.75 in the nearbys on Thursday. The Thursday morning Central Stockyards Fed Cattle online auction showed no sales on the 1,228 head offered, with bids at $226-228. Outside of that, Northern sales have been...
Via Barchart.com · November 6, 2025
Corn futures posted losses of 6 to 7 cents across the nearbys to close out the Thursday session. The CmdtyView national average Cash Corn price was down 6 1/4 cents to $3.89 3/4. China reportedly purchased a cargo of US sorghum overnight. Analysts e...
Via Barchart.com · November 6, 2025
Cotton futures were down 62 to 75 points in the front months on Thursday. Crude oil futures were down 7 cents/barrel to $59.53 on the day, with the US dollar index down $0.499 to $99.560. The Wednesday online auction from The Seam showed 2,463 bales...
Via Barchart.com · November 6, 2025
Soybeans were falling for much of the Thursday session with contracts closing 24 to 28 cents in the red. There were another 377 deliveries issued overnight, taking the total to 1,470 for the month. The cmdtyView national average Cash Bean price was 2...
Via Barchart.com · November 6, 2025
Power Solutions International (PSIX) reports record Q3 2025 earnings and revenue, crushing analyst estimates with 62% sales growth driven by data center demand.
Via Chartmill · November 6, 2025
Universal Display (OLED) stock fell after missing Q3 2025 earnings and revenue estimates. The company cited timing shifts and a one-time adjustment for the decline.
Via Chartmill · November 6, 2025
Onto Innovation (ONTO) beat Q3 2025 EPS estimates but missed on revenue. The company showed strong cost control and a robust cash position despite a sales decline.
Via Chartmill · November 6, 2025
Topgolf Callaway Brands (MODG) beat Q3 2025 earnings estimates by 76.9%, sparking a stock surge. The company raised its full-year guidance, signaling strong future confidence.
Via Chartmill · November 6, 2025
Prothena reports Q3 2025 earnings, provides updates on its neurodegenerative disease pipeline, and reaffirms strong cash position.
Via Chartmill · November 6, 2025
Five9 reported mixed Q3 2025 results, beating earnings estimates with record profitability but issuing slightly soft revenue guidance.
Via Chartmill · November 6, 2025
Evolent Health's Q3 2025 results show a revenue beat but a significant EPS miss. The stock surged on the news despite a 22.8% YoY revenue decline and conservative Q4 guidance.
Via Chartmill · November 6, 2025
Via Benzinga · November 6, 2025
Sunrun Q3 2025: Revenue beat estimates, but earnings miss led to a negative market reaction. Subscriber growth and storage attachment rates remained strong.
Via Chartmill · November 6, 2025
Progyny (PGNY) Q3 2025 earnings beat estimates with $313.3M in revenue and $0.45 EPS. The company raised its full-year guidance, driving a positive market reaction.
Via Chartmill · November 6, 2025
Alarm.com (ALRM) beat Q3 2025 earnings estimates and raised its full-year outlook, driven by strong SaaS revenue growth and profitability.
Via Chartmill · November 6, 2025
The Canadian Dollar held near steady against the U.S. Dollar on Thursday.
Via Talk Markets · November 6, 2025
Celanese (CE) reported mixed Q3 results, beating on adjusted EPS but missing on revenue. A large non-cash impairment charge led to a GAAP loss, while strategic moves like divestitures and debt reduction continued.
Via Chartmill · November 6, 2025
Despite posting growth in October, the company was hit with a mild analyst price target reduction.
Via The Motley Fool · November 6, 2025
Precision measurement company Mettler-Toledo (NYSE:MTD) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 7.9% year on year to $1.03 billion. On the other hand, next quarter’s revenue guidance of $1.08 billion was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $11.15 per share was 4.5% above analysts’ consensus estimates.
Via StockStory · November 6, 2025
Revelation Biosciences posts wider Q3 loss but secures funding, extends cash runway into 2026 following positive Gemini study data.
Via Chartmill · November 6, 2025
BuzzFeed stock plunges 27% after Q3 earnings miss, with revenue down 17% and a wider-than-expected loss per share.
Via Chartmill · November 6, 2025
The ONE Group (STKS) reported a major Q3 2025 earnings miss, with revenue and EPS falling far below Wall Street estimates, causing a sharp stock decline.
Via Chartmill · November 6, 2025
Direct Digital Holdings (DRCT) stock plummets 33.5% after Q3 2025 earnings miss revenue estimates by 65% and EPS forecasts.
Via Chartmill · November 6, 2025
Willdan Group's Q3 earnings crush estimates with a $1.21 EPS and $95M revenue, driving a 9% stock surge and a raised 2025 outlook.
Via Chartmill · November 6, 2025
Private markets investment firm StepStone Group (NASDAQ:STEP) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 118% year on year to $454.2 million. Its non-GAAP profit of $0.54 per share was 10.6% above analysts’ consensus estimates.
Via StockStory · November 6, 2025
OneStream (OS) Q3 2025 earnings crush estimates with EPS of $0.08 vs. $0.0241 forecast. Revenue also beats, sending the stock higher.
Via Chartmill · November 6, 2025
Chemours (CC) missed Q3 2025 earnings estimates, with EPS of $0.20 vs. $0.26 expected. Strong Opteon™ sales were offset by weak performance in other segments and a cautious Q4 outlook.
Via Chartmill · November 6, 2025
Sunrun shares were down after the company released a mixed third-quarter earnings report after Thursday's closing bell.
Via Benzinga · November 6, 2025
Farmer Brothers (FARM) Q1 fiscal 2026 results missed analyst estimates on both revenue and earnings per share, sending the stock lower.
Via Chartmill · November 6, 2025
Voice AI technology company SoundHound AI (NASDAQ:SOUN) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 67.6% year on year to $42.05 million. Its GAAP loss of $0.27 per share was significantly below analysts’ consensus estimates.
Via StockStory · November 6, 2025
Financial guidance platform NerdWallet (NASDAQ:NRDS) announced better-than-expected revenue in Q3 CY2025, with sales up 12.4% year on year to $215.1 million. Its non-GAAP profit of $0.34 per share was 7.3% above analysts’ consensus estimates.
Via StockStory · November 6, 2025
Nelnet (NNI) crushed Q3 earnings estimates with revenue of $427.8M and EPS of $2.95, driving a positive market reaction.
Via Chartmill · November 6, 2025
Veritone (VERI) Q3 2025 Earnings Call Transcript
Via The Motley Fool · November 6, 2025
Affirm Holdings (AFRM) reported strong Q1 2026 earnings, beating analyst estimates for both revenue and EPS. The stock surged over 10% in after-hours trading.
Via Chartmill · November 6, 2025
Doximity (DOCS) beat Q2 FY2026 earnings and revenue estimates, but shares fell on cautious future guidance. Revenue grew 23% YoY.
Via Chartmill · November 6, 2025
Allogene Therapeutics beat Q3 2025 earnings estimates with a narrower loss and reaffirmed its cash runway into 2027. The biotech also reported progress on its allogeneic CAR T pipeline.
Via Chartmill · November 6, 2025
Carlsmed (CARL) reported strong Q3 2025 results, beating revenue and EPS estimates with 98% YoY growth. The AI spine surgery firm also raised its full-year revenue guidance.
Via Chartmill · November 6, 2025
BeautyHealth (SKIN) stock surged over 16% after Q3 2025 results beat revenue estimates and showed strong profitability improvements.
Via Chartmill · November 6, 2025
MindMed (MNMD) Q3 2025 Earnings Call Transcript
Via The Motley Fool · November 6, 2025
10x Genomics (TXG) stock surged over 13% after beating Q3 2025 earnings estimates and providing strong Q4 revenue guidance, signaling investor optimism.
Via Chartmill · November 6, 2025
EOG Resources Q3 2025 earnings beat estimates by 10.5%, but revenue fell short. The mixed results led to a cautious market reaction.
Via Chartmill · November 6, 2025
Rocket Pharma posts a narrower-than-expected Q3 2025 loss. Key gene therapy pipeline advances include an FDA-accepted BLA for KRESLADI™ and a lifted clinical hold for its Danon Disease program.
Via Chartmill · November 6, 2025
USA Rare Earth posts a wider-than-expected Q3 2025 loss despite a strong cash position. The stock fell as operational losses deepen.
Via Chartmill · November 6, 2025
Monster Beverage shares were up after the company released its third-quarter earnings report after Thursday's closing bell.
Via Benzinga · November 6, 2025
aTyr Pharma's Q3 2025 results missed revenue and EPS estimates. Investors now focus on the upcoming 2026 FDA meeting for its lead drug, efzofitimod.
Via Chartmill · November 6, 2025